Volume : 08, Issue : 02, February – 2021
48.DEVELOPMENT AND VALIDATION OF RP-HPLC-PDA METHOD FOR THE QUANTIFICATION OF HESPERIDIN IN BULK AND ITS PHARMACEUTICAL DOSAGE FORM
Suman Narapureddy*, T. Veera Reddy, Varanasi S N Murthy
Abstract :
Flavonoids do have a lot of pharmacologic effects and health benefits. And are a group of polyphenolic compounds. For the effective delivery of flavonoids, to improve the bioavailability they are being formulated in many ways and for this an accurate analysis in a formulation, a suitable analytical method is needed. For the analysis of flavonoids, High-Performance Liquid Chromatography offers an accurate, sensitive technique. Hence in the present work, an attempt is made to develop and validate an economic, rapid and sensitive method for quantitative determination of Hesperidin in solid lipid nanoparticles based on isocratic reversed phase high-performance liquid chromatography. Chromatography was performed on a C-8 reverse-phase analytical column and photo diode array detector, the following conditions were chosen as optimal: mobile phase – Mobile phase A (methanol : acetonitrile – 60:40) 15% v/v: Mobile phase B (purified water acidified with 0.20 % ortho-Phosphoric acid-pH 2.5) 85% v/v, flow rate – 1.0 mL/min and ambient temperature. Linearity was observed in the concentration range 1-25 µg /mL with a correlation coefficient of 0.999 and the limit of detection (LOD) is 0.25µg/mL and limit of quantification (LOQ) is 0.81µg/mL. The proposed method allowed direct determination of Hesperidin with a high degree of accuracy, precision, robustness, specificity in solid lipid nanoparticles in the presence of formulation excipients.
Keywords: Hesperidin, Solid Lipid Nanoparticle Formulation, Quantitative Analysis, Isocratic Reverse Phase High-Performance Liquid Chromatography
Cite This Article:
Please cite this article in press Suman Narapureddy et al, Development And Validation Of RP-HPLC-PDA Method For The Quantification Of Hesperidin In Bulk And Its Pharmaceutical Dosage Form., Indo Am. J. P. Sci, 2021; 08(02).
Number of Downloads : 10
References :
1. Gacche, W. M. (2016). Anti-Inflammatory Properties of Hesperidin in Guinea Pigs. International Journal of Pharmacy and Pharmaceutical Research, 6(4).
2. Garg A, B. K. (2017). In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles. Int J Pharm, 120-130.
3. Kareem Rahn-Chique, A. M.-C.-V. (2012). Nanoemulsion stability: Experimental evaluation of the flocculation rate from turbidity measurements. Advances in Colloid and Interface Science, 1-20.
4. Kim KS, S. J. (2002). High-performance liquid chromatographic analysis of chrysin derivatives on a Nova-Pak C18 column. Arch Pharm Res, 613(6).
5. Md Khalid Anwer, R. A.-S.-K. (2014). Solubility of Bioactive Compound Hesperidin in Six Pure Solvents at. Journal of Chemical & Engineering Data, 2065−2069.
6. Mohammad Javed Ansari, M. K.-S. (2016). Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats. Drug Delivery, 23(6).
7. Pandey, S. K. (2013). Chemistry and Biological Activities of Flavonoids: An Overview. The ScientificWorld Journal, 16.